COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]
AstraZeneca
Press Releases – No new digest announcements identified
Bharat Biotech
Press Releases – No new digest announcements identified
BioCubaFarma – Cuba
Últimas Noticias – No new digest announcements identified
Biontech
Press Releases
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
16 February 2022
[See Perspectives above for detail]
CanSinoBIO
News – [Website not responding at inquiry]
Clover Biopharmaceuticals – China
News – No new digest announcements identified
Curevac [Bayer Ag – Germany]
News
February 10, 2022
CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK
Gamaleya National Center
Latest News and Events – See Russia below
IMBCAMS, China
Home – Website not responding at inquiry
Janssen/JNJ
Press Releases – No new digest announcements identified
Moderna
Press Releases
February 18, 2022
Moderna Expands Its mRNA Pipeline with Three New Development Programs
:: mRNA-1608 is a vaccine candidate against Herpes simplex virus (HSV)
:: mRNA-1468 is a vaccine candidate against varicella-zoster virus (VZV) to reduce the rate of herpes zoster (shingles)
:: mRNA-4359 is a new checkpoint cancer vaccine
February 16, 2022
Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)
Moderna Announces Plan to Expand Commercial Footprint in Europe Across Six Additional Countries
February 15, 2022
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Novavax
Press Releases
Health Canada Authorizes Novavax COVID-19 Vaccine
Feb 17, 2022
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine
Feb 14, 2022
Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland
Feb 14, 2022
Pfizer
Recent Press Releases
02.15.2022
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
Sanofi Pasteur
Press Releases – No new digest announcements identified
Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified
Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.
Sinopharm/WIBPBIBP
News – No new digest announcements identified
Sinovac
Press Releases
CUHK and SINOVAC Biotech (Hong Kong) Limited strategic collaboration framework agreement signing ceremony
2022/02/18
Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified
Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]
::::::
GSK
Press releases for media
GSK provides update on phase III RSV maternal vaccine candidate programme
18 February 2022 GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has voluntarily paused enrolment and vaccination in the GRACE phase III trial (NCT04605159), evaluating its potential respiratory syncytial virus (RSV) maternal vaccine candidate, as well as two other trials investigating this candidate in pregnant women (NCT04980391, NCT05229068).
This decision was made following a recommendation from the Independent Data Monitoring Committee based on an observation from a routine safety assessment. Monitoring safety signals is an integral part of the clinical development process for potential new vaccines…
Merck
News releases – No new digest announcements identified
Novartis
News – No new digest announcements identified
SK Biosciences
Press releases – No new digest announcements identified
Valneva
Press Releases – No new digest announcements identified
vaccines and global health :: ethics and policy 